MedTrace Logo

Autoimmune Intervention Mastery Course Study

NCT05057676 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2026-03-11

No results posted yet for this study

Summary

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remission with persisting fatigue.

Conditions

  • Multiple Sclerosis
  • Clinically Isolated Syndrome
  • Fibromyalgia
  • Post Acute Sequelae of COVID-19
  • Cancer in Remission With Persisting Fatigue

Interventions

BEHAVIORAL

Immediate Autoimmune Intervention Mastery Course (AIM)

Immediate access to an on line audio and video course with education about strategies to grow and improve resilience, diet quality, exercise, stress reduction and self-care

BEHAVIORAL

Immediate Question and Answer sessions. (AIM Q and A sessions)

Immediate access to videos answering common questions about the course concepts. One video released each week, 7 videos total.

BEHAVIORAL

Delayed Autoimmune Intervention Mastery Course (delayed AIM course)

Delayed access to an on line audio and video course with education about strategies to grow and improve resilience, diet quality, exercise, stress reduction and self-care

BEHAVIORAL

Delayed AIM Question and Answer sessions

Delayed access to videos answering common questions about the course concepts. One video released each week, 7 videos total.

Sponsors & Collaborators

  • Terry L. Wahls

    lead OTHER

Principal Investigators

  • Terry L Wahls, MD · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2027-12-01
Completion
2027-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05057676 on ClinicalTrials.gov